FIELD: medicine.
SUBSTANCE: eye drops for prophylactics and treatment of cataract, which contain such active reactants as biogenic compounds carnosine, taurine and glutathione. As carrier, eye drops contain low molecular microdispersed dextran ground for 9-11 minutes in vibration disk mill, and also contain benzalkonium chloride and purified water at certain ratios of components.
EFFECT: invention provides for prophylactics and treatment of cataract.
2 tbl, 4 dwg
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION IN FORM OF GEL FOR TREATING METABOLIC INVOLVEMENTS OF OCULAR TISSUES | 2014 |
|
RU2575558C1 |
DISULFIRAM AND TAURINE-CONTAINING OPHTHALMOLOGICAL MEDICATION IN FORM OF EYE DROPS | 2012 |
|
RU2485939C1 |
EYE DROPS FOR TREATING AGE-RELATED NUCLEAR CATARACT | 2019 |
|
RU2720676C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING EYE DISEASES RELATED TO EYE TISSUE METABOLIC DISEASE AND INFLAMMATORY EYE TISSUE INJURY | 2013 |
|
RU2521337C1 |
COMBINED OPHTHALMIC PREPARATION PRESENTED IN FORM OF EYE DROPS AND CONTAINING POLYHEXAMETHYLENE GUANIDINE AND TAURINE | 2012 |
|
RU2513997C1 |
THERAPY OF EARLY CATARACT | 2008 |
|
RU2367387C1 |
OCULAR DROPS WITH REPARATIVE AND ANTI-GLAUCOMA ACTION | 2005 |
|
RU2295331C2 |
IMPROVED EYE DROPS FOR PREVENTION AND TREATMENT OF EARLY MANIFESTATIONS OF AGE-RELATED NUCLEAR CATARACT | 2020 |
|
RU2748598C1 |
DRUG PREPARATION FOR TREATING CATARACT AND METHOD FOR PREPARING IT (VERSIONS) | 2012 |
|
RU2536958C2 |
COMBINED OPHTHALMIC AGENT | 2019 |
|
RU2733392C1 |
Authors
Dates
2010-11-27—Published
2009-10-28—Filed